Showing results (601-610 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|July 29, 2024
A rare adverse effect in inebilizumab therapy for neuromyelitis optica spectrum disorder: a case reportXuefen Chen, Ziyan Shi, Rui Wang, et al.Therapeutic Advances in Neurological Disorders|November 28, 2022
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative reviewVictor Constantinescu, Rocco Haase, Katja Akgün, et al.Therapeutic Advances in Neurological Disorders|November 28, 2022
Diagnosis and treatment of acute isolated proximal internal carotid artery occlusions: a narrative reviewOdysseas Kargiotis, Klearchos Psychogios, Apostolos Safouris, et al.Therapeutic Advances in Neurological Disorders|December 21, 2020
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patientsMario Stampanoni Bassi, Jelena Drulovic, Tatjana Pekmezovic, et al.Therapeutic Advances in Neurological Disorders|March 14, 2013
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisCharles Pierrot-Deseilligny, Jean-Claude SouberbielleTherapeutic Advances in Neurological Disorders|January 2, 2013
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosisPaul I Creeke, Rachel A FarrellTherapeutic Advances in Neurological Disorders|July 17, 2013
Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesityBarbara R Sommer, Erica L Mitchell, Tonita E WroolieTherapeutic Advances in Neurological Disorders|September 3, 2013
Sumatriptan/naproxen sodium combination versus its components administered concomitantly for the acute treatment of migraine: a pragmatic, crossover, open-label outcomes studyStephen Landy, Rebecca Hoagland, Dakota Hoagland, et al.Therapeutic Advances in Neurological Disorders|September 3, 2013
A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic painGanesan Baranidharan, Sangeeta Das, Arun BhaskarTherapeutic Advances in Neurological Disorders|May 17, 2012
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and moreMarie Cathrin Mayer, Edgar MeinlPageof 108